Deutsche Bank Starts Caesars Entertainment (CZR) at Hold; Upside Potential Equals Downside Risk
Get Alerts CZR Hot Sheet
Price: $29.76 +0.40%
Rating Summary:
7 Buy, 22 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
7 Buy, 22 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Deutsche Bank initiates coverage on Caesars Entertainment (NASDAQ: CZR) with a Hold. PT $16.00.
Deutsche analyst said, "While we find several aspects of the CZR story compelling, namely; 1) leverage to an accelerating LV recovery, 2) the operating leverage inherent in CZR’s LV and regional operations, 3) a steady stream of low risk high reward development opportunities, and 4) a leading position in the event the U.S. legalizes online gaming, we ultimately believe that for the stock to work from a fundamental standpoint, “You Gotta Believe”. Given our view of risks and current valuation, we are initiating coverage with a Hold."
For an analyst ratings summary and ratings history on Caesars Entertainment click here. For more ratings news on Caesars Entertainment click here.
Shares of Caesars Entertainment closed at $12.99 yesterday.
Deutsche analyst said, "While we find several aspects of the CZR story compelling, namely; 1) leverage to an accelerating LV recovery, 2) the operating leverage inherent in CZR’s LV and regional operations, 3) a steady stream of low risk high reward development opportunities, and 4) a leading position in the event the U.S. legalizes online gaming, we ultimately believe that for the stock to work from a fundamental standpoint, “You Gotta Believe”. Given our view of risks and current valuation, we are initiating coverage with a Hold."
For an analyst ratings summary and ratings history on Caesars Entertainment click here. For more ratings news on Caesars Entertainment click here.
Shares of Caesars Entertainment closed at $12.99 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Needham Starts Faeth Therapeutics (FTH) at Buy
- BNP Paribas Exane Starts NIQ Global Intelligence Plc (NIQ) at Outperform
- William Blair Starts Beta Bionics, Inc. (BBNX) at Market Perform
Create E-mail Alert Related Categories
New CoverageRelated Entities
Deutsche BankSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share